Cargando…

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies

Alzheimer’s disease (AD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) represent the three major neurodegenerative dementias characterized by abnormal brain protein accumulation. In this study, we investigated extracellular vesicles (EVs) and neurotrophic factors in the cerebros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longobardi, Antonio, Nicsanu, Roland, Bellini, Sonia, Squitti, Rosanna, Catania, Marcella, Tiraboschi, Pietro, Saraceno, Claudia, Ferrari, Clarissa, Zanardini, Roberta, Binetti, Giuliano, Di Fede, Giuseppe, Benussi, Luisa, Ghidoni, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834088/ https://www.ncbi.nlm.nih.gov/pubmed/35159272 http://dx.doi.org/10.3390/cells11030462

Ejemplares similares

Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia
por: Longobardi, Antonio, et al.
Publicado: (2021)

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
por: Nicsanu, Roland, et al.
Publicado: (2022)

Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
por: Benussi, Luisa, et al.
Publicado: (2021)

N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease
por: Domingo, Guido, et al.
Publicado: (2021)

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022)

Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration
por: Rossi, Giacomina, et al.
Publicado: (2022)

Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper
por: Sacco, Anna, et al.
Publicado: (2022)

Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
por: Benussi, Luisa, et al.
Publicado: (2017)

Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
por: Borin, Mirta, et al.
Publicado: (2018)

A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides
por: Ghidoni, Roberta, et al.
Publicado: (2011)

Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders
por: Zanardini, Roberta, et al.
Publicado: (2016)

Copper Imbalance in Alzheimer’s Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants
por: Squitti, Rosanna, et al.
Publicado: (2021)

Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia
por: Moretti, Davide V., et al.
Publicado: (2016)

The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
por: Ciani, Miriam, et al.
Publicado: (2019)

Pathological 25 kDa C-Terminal Fragments of TDP-43 Are Present in Lymphoblastoid Cell Lines and Extracellular Vesicles from Patients Affected by Frontotemporal Lobar Degeneration and Neuronal Ceroidolipofuscinosis Carrying a GRN Mutation
por: Cimini, Sara, et al.
Publicado: (2022)

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity()
por: Diomede, Luisa, et al.
Publicado: (2014)

Molecular subtypes of Alzheimer’s disease
por: Di Fede, Giuseppe, et al.
Publicado: (2018)

Prodromal frontotemporal dementia: clinical features and predictors of progression
por: Benussi, Alberto, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
por: Benussi, Alberto, et al.
Publicado: (2018)

Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
por: Pal, Amit, et al.
Publicado: (2022)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research
por: Ciani, Miriam, et al.
Publicado: (2019)

tDCS-Induced Memory Reconsolidation Effects: Analysis of Prominent Predicting Factors
por: Cotelli, Maria, et al.
Publicado: (2022)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease
por: Serpente, Maria, et al.
Publicado: (2020)

Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF)
por: Akers, Johnny C., et al.
Publicado: (2016)

Extracellular Vesicles in Alzheimer’s Disease: Friends or Foes? Focus on Aβ-Vesicle Interaction
por: Joshi, Pooja, et al.
Publicado: (2015)

Occipital atrophy signature in prodromal Lewy bodies disease
por: Galli, Alice, et al.
Publicado: (2023)

Imbalance of Essential Metals in Traumatic Brain Injury and Its Possible Link with Disorders of Consciousness
por: Squitti, Rosanna, et al.
Publicado: (2023)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
por: van de Beek, M., et al.
Publicado: (2020)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
por: Catania, Marcella, et al.
Publicado: (2019)

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
por: Maetzler, Walter, et al.
Publicado: (2012)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
por: Akers, Johnny C., et al.
Publicado: (2013)

Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication
por: Moeng, Sokviseth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_omo0bijed7245ejrt7kiibj62b